Bone Biologics (BBLG) Other Accumulated Expenses (2013)

Bone Biologics (BBLG) reported Other Accumulated Expenses of $75000.0 for Q4 2013.

Bone Biologics (BBLG) Other Accumulated Expenses (2013) Analysis & Trends

Bone Biologics (BBLG) has 1 years of Other Accumulated Expenses data on file, last reported at $75000.0 in Q4 2013.

Other Accumulated Expenses for Q4 2013 came in at $75000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2013 was $75000.0 (changed N/A YoY), and the FY2013 annual result was $75000.0, changed N/A from the prior year.
Other Accumulated Expenses was little changed at $75000.0 in Q4 2013 per BBLG's latest filing.
Over five years, Other Accumulated Expenses peaked at $75000.0 in Q4 2013 and troughed at $75000.0 in Q4 2013.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn
9	Abivax	95.45 Bn	95.45 Bn	-
10	Bone Biologics	1.47 Mn	1.47 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2013	75,000.00